News

Gorodissky & Partners law firm held the seminar ‘Intellectual Assets as the Basis for Competitive Advantage’, which was organized jointly with the Ministry of Science, Higher Education and Innovations of the Kyrgyz Republic (Patent Office) in Bishkek.

Gorodissky & Partners law firm in collaboration with the Ministry of Science, Higher Education and Innovation of the Kyrgyz Republic held a guest lecture on intellectual property for faculty members, students, postgraduates and master's degree candidates of the Law Institute of Kyrgyz National University n.a. J. Balasagyn.

The 161 (2025) issue of the G-News newsletter has been released. It includes an article by Stanislav Rumyantsev, Ph.D., CIPP/E, Senior lawyer (Gorodissky & Partners, Moscow) «Russia Introduced New Rules On Data Processing Consent», a new section “Alerts from our foreign offices” and an overview of news in the field of intellectual property in Russia and CIS countries.

Yuri Kuznetsov, Senior Partner, Russian Patent Attorney, Eurasian Patent & Design Attorney, Head of Patent Practice, Alexander Vladimirov, Ph.D., Russian and Eurasian Patent Attorney, Deputy Head of Electronics & Physics Department, Andrey Rogov, Head of Computer Systems Department (all - Gorodissky & Partners, Moscow), Cholpon Dootalieva, Kyrgyz Patent Attorney, Regional Director, (Gorodissky & Partners, Bishkek) and Arman Sauganbayev, Kazakh Patent Attorney, Eurasian Patent & Design Attorney, Regional Director (Gorodissky & Partners, Kazakhstan) was host the session "Artificial Intelligence as a Phenomenon, Tool and Intellectual Property" within the framework of the IV Eurasian Conference on Intellectual Property and Technologies "IP Eurasia / IP Kazakhstan'2025" in Astana.

Gorodissky & Partners improved its leading positions in the federal ranking of law firms “Pravo-300” in the following categories: "Intellectual Property (Litigation)", "Intellectual Property (Consulting)", "Intellectual Property (Registration)", “Personal Data” (all- Group I),  “TMT (telecommunications, media, technology)” and Pharmaceuticals and Healthcare (Pharmaceuticals) (both - Group II).